BioSpace News Archive

Deals

LNC Therapeutics raises €6.2 million for the clinical development of new generation gut microbiome based drugs

Bordeaux, France, September 05th 2019 – LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery, announced that it has raised €6.2 million via a capital increase and non-dilutive funding.

September 8, 2019
·
4 min read
Business

Dr. Barry Arkles, President and CTO of Gelest, Receives ACS 2020 Kipping Award

Gelest, Inc., a leading innovator in materials science, announced that its Founder, President and Chief Technology Officer Dr. Barry Arkles is the recipient of the American Chemical Society 2020 Frederic Stanley Kipping Award in Silicon Chemistry.

September 8, 2019
·
3 min read
Job Trends

The Paradox of Different House Flies with Few Genetic Differences

UH Evolutionary Biologist Publishes Findings on Sex Determinates of House Flies

September 8, 2019
·
2 min read
Business

Tuskegee University workshops seek to increase awareness, hope among those at highest risk for cervical cancer

Aug. 26, faculty from Tuskegee University traveled to Union Springs, Alabama, with a message of hope for women ranging from middle-school age to adulthood — hope, and real preventative measures for falling victim to cervical cancer.

September 8, 2019
·
6 min read
Deals

BioCity Invests in Early-stage Precision Medicine Biotech

BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator.

September 8, 2019
·
4 min read
Business

Case Western Reserve University and Akouos sign exclusive licensing agreement to advance development of gene therapy technology as a potential treatment for a type of Usher syndrome

Case Western Reserve University and Boston-based Akouos have entered into an exclusive licensing agreement to develop a patented gene therapy with the potential to treat hearing loss associated with a type of Usher syndrome, the most common deaf-blind disorder.

September 8, 2019
·
3 min read
Microbix Quality Products Attain European Registration

Four IVD Controls to Support Performance of Human Papilloma Virus Tests

September 8, 2019
·
5 min read
Business

MaRS Innovation Announces Name Change to Toronto Innovation Acceleration Partners

MaRS Innovation is pleased to announce that, on its 10th anniversary, it has changed its name to Toronto Innovation Acceleration Partners to reflect its refined focus on venture building and growth to advance its Members’ health science innovations .

September 8, 2019
·
2 min read
Business

David Mayo joins Verita Healthcare as Group Sales and Marketing Director

Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.

September 8, 2019
·
4 min read
Business

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

Crescendo Biologics Ltd announces that Stewart Kay has been appointed as the Company’s Chief Business Officer.

September 8, 2019
·
3 min read